TITLE

Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells

AUTHOR(S)
Ratajczak, J.; Zuba-Surma, E.; Klich, I.; Liu, R.; Wysoczynski, M.; Greco, N.; Kucia, M.; Laughlin, M. J.; Ratajczak, M. Z.
PUB. DATE
August 2011
SOURCE
Leukemia (08876924);Aug2011, Vol. 25 Issue 8, p1278
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
A population of CD133(+)Lin(-)CD45(-) very small embryonic/epiblast-like stem cells (VSELs) has been purified by multiparameter sorting from umbilical cord blood (UCB). To speed up isolation of these cells, we employed anti-CD133-conjugated paramagnetic beads followed by staining with Aldefluor to detect aldehyde dehydrogenase (ALDH) activity; we subsequently sorted CD45(-)/GlyA(-)/CD133(+)/ALDH(high) and CD45(-)/GlyA(-)/CD133(+)/ALDH(low) cells, which are enriched for VSELs, and CD45(+)/GlyA /CD133(+)/ALDH(high) and CD45(+)/GlyA(-)/CD133(+)/ALDH(low) cells, which are enriched for hematopoietic stem/progenitor cells (HSPCs). Although freshly isolated CD45(-) VSELs did not grow hematopoietic colonies, the same cells, when activated/expanded over OP9 stromal support, acquired hematopoietic potential and grew colonies composed of CD45(+) hematopoietic cells in methylcellulose cultures. We also observed that CD45(-)/GlyA(-)/CD133(+)/ALDH(high) VSELs grew colonies earlier than CD45(-)/GlyA(-)/CD133(+)/ALDH(low) VSELs, which suggests that the latter cells need more time to acquire hematopoietic commitment. In support of this possibility, real-time polymerase chain reaction analysis confirmed that, whereas freshly isolated CD45(-)/GlyA(-)/CD133(+)/ALDH(high) VSELs express more hematopoietic transcripts (for example, c-myb), CD45(-)/GlyA(-)/CD133(+)/ALDH(low) VSELs exhibit higher levels of pluripotent stem cell markers (for example, Oct-4). More importantly, hematopoietic cells derived from VSELs that were co-cultured over OP9 support were able to establish human lympho-hematopoietic chimerism in lethally irradiated non-obese diabetic/severe combined immunodeficiency mice 4-6 weeks after transplantation. Overall, our data suggest that UCB-VSELs correspond to the most primitive population of HSPCs in UCB.
ACCESSION #
64003155

 

Related Articles

  • Ectopic Runx1 Expression Rescues Tal-1-Deficiency in the Generation of Primitive and Definitive Hematopoiesis. Tornack, Julia; Seiler, Katharina; Grützkau, Andreas; Grün, Joachim R.; Onodera, Masafumi; Melchers, Fritz; Tsuneto, Motokazu // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The transcription factors SCL/Tal-1 and AML1/Runx1 control the generation of pluripotent hematopoietic stem cells (pHSC) and, thereby, primitive and definitive hematopoiesis, during embryonic development of the mouse from mesoderm. Thus, Runx1-deficient mice generate primitive, but not...

  • Mesodermal and Hematopoietic Differentiation from ES and iPS Cells. Inoue-Yokoo, Tomoko; Tani, Kenzaburo; Sugiyama, Daisuke // Stem Cell Reviews & Reports;Aug2013, Vol. 9 Issue 4, p422 

    Embryonic stem (ES) and induced pluripotent stem (iPS) cells can differentiate into any type of tissue when grown in a suitable culture environment and are considered valuable tools for regenerative medicine. In the field of hematology, generation of hematopoietic stem cells (HSCs) and mature...

  • Embryonic Stem Cell-Derived Hematopoietic Stem Cells: Challenges in Development, Differentiation, and Immunogenicity. Thompson, H. L.; Manilay, J. O. // Current Topics in Medicinal Chemistry;Jul2011, Vol. 11 Issue 13, p1621 

    Embryonic stem cells (ESC) can potentially be manipulated in vitro to differentiate into cells and tissues of all three germ layers. This pluripotent feature is being exploited to use ESC-derived tissues as therapies for degenerative diseases and replacement of damaged organs. Although their...

  • Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells. Chang, Chia-Wei; Lai, Yi-Shin; Lamb Jr., Lawrence S.; Townes, Tim M. // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Human induced pluripotent stem cells (hiPSCs) have enormous potential for the treatment of inherited and acquired disorders. Recently, antigen-specific T lymphocytes derived from hiPSCs have been reported. However, T lymphocyte populations with broad T cell receptor (TCR) diversity have not been...

  • MicroRNA-199a induces differentiation of induced pluripotent stem cells into endothelial cells by targeting sirtuin 1. ZHOUBIN LI; MARGARITI, ANDRIANA; YUTAO WU; FENG YANG; JIAN HU; LI ZHANG; TING CHEN // Molecular Medicine Reports;2015, Vol. 12 Issue 3, p3711 

    The ability to reprogram induced pluripotent stem (iPS) cells from somatic cells may facilitate significant advances in regenerative medicine. MicroRNAs (miRNAs) are involved in a number of core biological processes, including cardiogenesis, hematopoietic lineage differentiation and oncogenesis....

  • Design of stapled α-helical peptides to specifically activate Wnt/β-catenin signaling. Cui, Hong-Kui; Zhao, Bing; Li, Yehua; Guo, Ye; Hu, Hao; Liu, Lei; Chen, Ye-Guang // Cell Research;Apr2013, Vol. 23 Issue 4, p581 

    The article discusses research which examines the development of the design of hydrocarbon-stapled helical peptides to mimic the α-helix conformation of folded proteins. The study indicates the capability of Wnt/β-catenin signaling pathway to orchestrate cell morphology, differentiation...

  • Production of Hematopoietic Cells From Umbilical Cord Blood Stem Cells for Transfusion Purposes: Focus on Ex Vivo Generation of Red Blood Cells. Ivanovic, Zoran; Vlaski, Marija // Scripta Medica;2012, Vol. 43 Issue 2, p99 

    Cord blood contains a heterogeneous population of stem cells and progenitors and, in addition to transplantation these cells could be used also for ex vivo production of mature cells, as red blood cells (RBC). The experimental ex vivo production of RBC, first demonstrated with cord blood CD34+...

  • Generation of Engraftable Hematopoietic Stem Cells From Induced Pluripotent Stem Cells by Way of Teratoma Formation. Suzuki, Nao; Yamazaki, Satoshi; Yamaguchi, Tomoyuki; Okabe, Motohito; Masaki, Hideki; Takaki, Satoshi; Otsu, Makoto; Nakauchi, Hiromitsu // Molecular Therapy;Jul2013, Vol. 21 Issue 7, p1424 

    In vitro generation of hematopoietic stem cells (HSCs) from induced pluripotent stem cells (iPSCs) has the potential to provide novel therapeutic approaches for replacing bone marrow (BM) transplantation without rejection or graft versus host disease. Hitherto, however, it has proved difficult...

  • Generation and Homing of iPSC-Derived Hematopoietic Cells In Vivo. Chou, Bin-Kuan; Ye, Zhaohui; Cheng, Linzhao // Molecular Therapy;Jul2013, Vol. 21 Issue 7, p1292 

    The author comments on the article "Generation of engraftable hematopoietic stem cells (HSC) from induced pluripotent stem cells (iPSC) by way of teratoma formation," by N. Suzuki et al. The iPSC-derived HSC-like cells were demonstrated to be existing within the teratoma as well as within the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics